Medial temporal lobe (MTL) atrophy is a key feature of Alzheimer's disease (AD), however, it also occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better understand the differential effects of age and AD by encompassing the full AD-continuum from cognitively unimpaired (CU) to dementia, including all MTL subregions with up-to-date approaches and using longitudinal designs to assess atrophy more sensitively. Age-related trajectories were estimated using the best-fitted polynomials in 209 CU adults (aged 19-85). Changes related to AD were investigated among amyloid-negative (Aβ-) ( = 46) and amyloid-positive (Aβ+) ( = 14) CU, Aβ+ patients with mild cognitive impairment (MCI) ( = 33) and AD ( = 31). Nineteen MCI-to-AD converters were also compared with 34 non-converters. Relationships with cognitive functioning were evaluated in 63 Aβ+ MCI and AD patients. All participants were followed up to 47 months. MTL subregions, namely, the anterior and posterior hippocampus (aHPC/pHPC), entorhinal cortex (ERC), Brodmann areas (BA) 35 and 36 [as perirhinal cortex (PRC) substructures], and parahippocampal cortex (PHC), were segmented from a T1-weighted MRI using a new longitudinal pipeline (LASHiS). Statistical analyses were performed using mixed models. Adult lifespan models highlighted both linear (PRC, BA35, BA36, PHC) and nonlinear (HPC, aHPC, pHPC, ERC) trajectories. Group comparisons showed reduced baseline volumes and steeper volume declines over time for most of the MTL subregions in Aβ+ MCI and AD patients compared to Aβ- CU, but no differences between Aβ- and Aβ+ CU or between Aβ+ MCI and AD patients (except in ERC). Over time, MCI-to-AD converters exhibited a greater volume decline than non-converters in HPC, aHPC, and pHPC. Most of the MTL subregions were related to episodic memory performances but not to executive functioning or speed processing. Overall, these results emphasize the benefits of studying MTL subregions to distinguish age-related changes from AD. Interestingly, MTL subregions are unequally vulnerable to aging, and those displaying non-linear age-trajectories, while not damaged in preclinical AD (Aβ+ CU), were particularly affected from the prodromal stage (Aβ+ MCI). This volume decline in hippocampal substructures might also provide information regarding the conversion from MCI to AD-dementia. All together, these findings provide new insights into MTL alterations, which are crucial for AD-biomarkers definition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554299PMC
http://dx.doi.org/10.3389/fnagi.2021.750154DOI Listing

Publication Analysis

Top Keywords

mtl subregions
24
aβ+ mci
16
mci patients
12
medial temporal
8
temporal lobe
8
alzheimer's disease
8
mtl
8
aβ+
8
aβ+ aβ+
8
mci-to-ad converters
8

Similar Publications

Article Synopsis
  • The study aims to examine brain abnormalities in patients with eye trauma (ET) by comparing their brain activity with healthy controls using functional magnetic resonance imaging (fMRI).
  • Findings show that ET patients have significantly increased functional connectivity between various brain regions, including areas involved in memory and cognitive processes, with no observed decreases in connectivity within the default mode network.
  • The results suggest that the brain regions affected in ET patients may be dysfunctional, potentially providing insights into the underlying mechanisms associated with eye trauma.
View Article and Find Full Text PDF

Background: Lewy body disorders (LBD), encompassing Parkinson disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB), are characterized by alpha-synuclein pathology but often are accompanied by Alzheimer's disease (AD) neuropathological change (ADNC). The medial temporal lobe (MTL) is a primary locus of tau accumulation and associated neurodegeneration in AD. However, it is unclear the extent to which AD copathology in LBD (LBD/AD+) contributes to MTL-specific patterns of degeneration.

View Article and Find Full Text PDF

Background: Research has increasingly recognized sex differences in aging and Alzheimer's Disease (AD) susceptibility. However, sex effects on the medial temporal lobe (MTL), a crucial region affected by aging and AD, remain poorly understood when it comes to the intricacies of morphology and functional connectivity. This study aimed to systematically analyze structural and functional connectivity among MTL subregions, which are known to exhibit documented morphological sex differences, during midlife, occurring before the putative pivotal age of cerebral decline.

View Article and Find Full Text PDF

Early stages of Alzheimer's disease (AD) are associated with volume reductions in specific subregions of the medial temporal lobe (MTL). Using a manual segmentation method-the Olsen-Amaral-Palombo (OAP) protocol-previous work in healthy older adults showed that reductions in grey matter volumes in MTL subregions were associated with lower scores on the Montreal Cognitive Assessment (MoCA), suggesting atrophy may occur prior to diagnosis of mild cognitive impairment, a condition that often progresses to AD. However, current "gold standard" manual segmentation methods are labour intensive and time consuming.

View Article and Find Full Text PDF

Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer's disease.

Alzheimers Res Ther

September 2024

Department of Diagnostic Radiology, Clinical Sciences, Lund University, Klinikgatan 13B, Lund, SE-22242, Sweden.

Article Synopsis
  • The medial temporal lobe (MTL), thought to be relatively unaffected in early-onset Alzheimer's disease (EOAD), was examined in detail to understand atrophy patterns among different age groups of Alzheimer's patients.
  • The study included participants with memory issues and abnormal brain scans, comparing 41 EOAD individuals under 65 years old with 154 late-onset Alzheimer's (aLOAD) patients aged 70 or older, alongside cognitively healthy controls.
  • Findings revealed that both EOAD and aLOAD groups had smaller MTL regions compared to controls, with specific differences in brain structure and pathology but no significant differences in tau pathology levels between the two Alzheimer's groups.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!